TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21CA162259
National Institutes of Health
Grant: P20MD006988
National Institutes of Health
Grant: R25GM060507
National Institutes of Health
Grant: R01HL095120
National Institutes of Health
Grant: R01CA209829
National Institutes of Health
Grant: R43CA224723
NCI NIH HHS
Grant: R01 CA213912
GCAT
LLU Center for Health Disparities & Molecular Medicine and the Department of Pathology and Human Anatomy
GRASP
St. Baldrick’s Foundation
Loma Linda University
FWCI
2.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals